AZARGA 10 mg/ml + 5 mg/ml, eye drop suspension bottle, 5 ml
Active ingredients: Brinzolamide, Timolol maleate, TIMOLOL BASE
Commercialized according to BDPMDispensing in France: Prescription only
Eye drop suspensionbottle, 5 mlophtalmique
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- AZARGA 10 mg/mL + 5 mg/mL, collyre en suspension
- Pharmaceutical form
- collyre en suspension
- Route of administration
- ophtalmique
- Presentation description
- 1 flacon(s) polyéthylène basse densité (PEBD) de 5 ml avec embout(s)
- Marketing authorisation holder
- NOVARTIS EUROPHARM (IRLANDE)
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 2 Apr 2009
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
65711858CIP73912664CIP133400939126647Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| MALÉATE DE TIMOLOLcollyre | 6,8 mg · 1 ml | SA |
| TIMOLOL BASEcollyre | 5 mg · 1 ml | FT |
| BRINZOLAMIDEcollyre | 10 mg · 1 ml | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.